Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding ARKG?
Track your performance easily
ARKG Price & Analysis
ARKG ETF Chart & Stats
Day’s Range― - ―
52-Week Range$24.70 - $38.97
Previous Close$25.75
VolumeN/A
Average Volume (3M)1.45M
AUM1.57B
NAV25.76
Expense Ratio0.75%
Holdings Count41
Beta1.73
Inception DateOct 31, 2014
Last Dividend Ex-Date
Dec 29, 2021Dividend YieldN/A
Shares Outstanding65,109,058
Standard Deviation0.12
10 Day Avg. Volume1,757,031
30 Day Avg. Volume1,452,248
Alpha-0.00696
ARKG ETF News
ARKG ETF FAQ
What was ARKG’s price range in the past 12 months?
ARKG lowest ETF price was $24.70 and its highest was $38.97 in the past 12 months.
What is the AUM of ARKG?
As of Oct 17, 2023 The AUM of ARKG is 1.57B.
Is ARKG overvalued?
According to Wall Street analysts ARKG’s price is currently Undervalued.
Does ARKG pay dividends?
ARKG pays a Annually dividend of $0.38 which represents an annual dividend yield of N/A. See more information on ARKG dividends here
How many shares outstanding does ARKG have?
ARKG has 65,109,058 shares outstanding.
Which hedge fund is a major shareholder of ARKG?
Among the largest hedge funds holding ARKG’s share is ARK Investment Management LLC. It holds ARKG’s shares valued at 109K.
ARKG ETF Smart Score
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Exact Sciences Corp
10.43%
Ionis Pharmaceuticals Inc.
7.09%
Pacific Biosciences
5.90%
Ginkgo Bioworks Holdings, Inc.
5.50%
Teladoc Inc.
4.65%
Crispr Therapeutics
4.40%
Schrodinger, Inc.
4.17%
Intellia Therapeutics Inc
3.98%
Uipath Inc
3.51%
Beam Therapeutics, Inc.
3.19%
Total52.82%
ETF Description
ARK Genomic Revolution ETF
ARKG is an actively managed fund that targets companies involved in the genomics industry.